Washington, Novavax has developed a new vaccine that targets both Covid-19 and the flu and triggers an immune response similar to its stand-alone shots against each virus, the company said.…
By Pushkala Aripaka and Francesco Guarascio The European Union on Monday approved the use of Novavax’s COVID-19 vaccine in people 18 years and older, giving a boost to the U.S.…
By Mike Corder The Hague, Dec 20 (AP) The European Union’s drugs regulator gave the green light Monday to a fifth COVID-19 vaccine for use in the 27-nation bloc, granting…
By Pushkala Aripaka and Lucy Marks A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of…
By Michael Head, University of Southampton Southampton (UK) The pandemic has been rumbling on for two years and is probably going to rumble on for years to come. And despite…
